[ad_1]
CoronaVac vaccine against the COVID-19 pandemic Developed by Sinovac Biotech Ltd of China, it showed 50-90% efficiency in tests conducted in Brazil, according to the Sao Paulo state minister of Health, following concerns expressed Wednesday about the failure of the data. The results of the tests in Brazil are being released exclusively by the Butantan Institute, a biomedical research center that has agreed with Sinovac to produce the vaccine, according to the State Health Minister, Jean Gorindstein.
Preliminary tests showed an efficiency of more than 50%, a minimum requirement from the Brazilian health regulator, Anvisa, and an efficiency of less than 90%, Gorindstein said in an interview with CBN radio last night.
At Sinovac’s request, the Sao Paulo Ministry of Health did not receive the full results of the tests from the Chinese pharmaceutical company, the minister said, adding that the company would review the test data before announcing the final results.
Source ΑΠΕ-Fuente
News Today:
Ohio police kill cold nigger in his garage
Coronavirus cases: the outlook in hospitals across the country
With the seal of the CoE 12 miles from the territorial waters in the Ionian
